Skip to main content

Table 1 Patient & tumor characteristics

From: Response criteria in solid tumors (PERCIST/RECIST) and SUVmax in early-stage non-small cell lung cancer patients treated with stereotactic body radiotherapy

Gender

 

 Female

53 (66%)

 Male

42 (44%)

Age at Treatment Outset

 

 Median (years)

75

 Range (years)

51–92

Smoking History

 

 Former

59 (62%)

 Current

29 (31%)

 Never

7 (7%)

Pack-Years Smoking

 

 Median (pack-years)

50

 Range (pack-years)

0.75–210

AJCC Stage

 

 IA

67 (71%)

 IB

27 (28%)

 IIA

1 (1%)

Gross Tumor Volume

 

 Median (cm3)

9.4

 Range (cm3)

1.3–193.5

Longest Tumor Dimension

 

 Median (cm)

2.3

 Range (cm)

1.0–5.4

Charlson Comorbidity Index (non-age factored)

 

 Median

4

 Range

2–8

NSCLC Histology

 

 Squamous

29 (31%)

 Adenocarcinoma

35 (37%)

 Bronchial Alveolar Cell

2 (2%)

 Poorly Differentiated

4 (4%)

 Atypical

25 (26%)